VERU NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Veru Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 2.24 USD
-0.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -10.6% below the Trend Line and sits at 3.6% of its 52-week range. The latest completed week returned -0.4%, after a -26.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 54/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 9d.

Setup score 17 out of 100
Latest Close 2.24 USD 31 Jul 2026
1W Return -0.4% latest completed week
4W Return -26.8% short-term follow-through
12W Return 0.0% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • 7 accumulation markers appear in the recent smart-money tape.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 43.54% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.4% Latest completed week; four-week move -26.8%. Indicator stack 8/49 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.54% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 54/100 conviction; expected move 10.6%. News sentiment 54/100 36 relevant articles in the latest sentiment read. Event risk 9d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -10.6% below the Trend Line and sits at 3.6% of its 52-week range. The latest completed week returned -0.4%, after a -26.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3212-week average 0.18

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.32Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

7 accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -26.8% over four weeks, 0.0% over 12 weeks, and -54.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-0.4%
4W-26.8%
12W0.0%
26W-11.5%
52W-54.6%
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.31Latest activity-pressure read.
Pressure change-77.5%Four-week change in activity pressure.
Leadership-26.29Latest relative-leadership reading.
RS change-104.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength31/100Blend of value, momentum, and quality. Underlying universe rank 70; rank 1 is best.
Value41/100Relative valuation strength. Underlying universe rank 60; rank 1 is best.
Quality40/100Profitability and accounting quality. Underlying universe rank 61; rank 1 is best.
Momentum42/100Medium-term price momentum. Underlying universe rank 59; rank 1 is best.
Growth42/100Revenue and earnings growth. Underlying universe rank 59; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
119.0x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-229.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-37.7%
Gross profit retained from each unit of revenue.
Operating margin
-9271.2%
Operating profit retained from revenue.
Free-cash-flow margin
-8587.3%
Free cash flow generated from revenue.
Return on invested capital
-210.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-97.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
0/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-64.7%
Net share repurchases relative to market value.
Shareholder yield
-64.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

VERU shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 0.01, expected move of 10.6%, and Sharemaestro trend signal active.

Conviction54/100
Expected move10.6%
Put/call volume0.01
Pressure100
Speculation11
Volatility96
Trend agreement0
Open options detail
Insider activity8 / 0

8 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 36 relevant articles.

7 positive · 27 neutral · 2 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings9dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move10.6%Nearest-chain priced movement where available.
52-week drawdown-69.4%Distance below the 52-week high.
13-week volatility13.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+43.5%Week of 5 Jun.
Worst week-14.4%Week of 17 Jul.
Latest week-0.4%Week of 31 Jul.

Shape of recent returns

Strong gains4
Modest gains6
Flat weeks0
Modest losses6
Sharp losses10
Recent vol13.9%13-week weekly-return volatility.
Base vol9.9%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew6.2% / -7.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape20/100

Trend, activity pressure, participation, and risk combine to a 20/100 tape read.

 Indicator analysis60/100

Latest 12-week confirmation: trend 8/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.32; No reversal markers Next-Week ExpectancyNegative 43.54%

Next-week expectancy is negative with a 43.54% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors37/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 98 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options36/100

VERU shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 0.01, expected move of 10.6%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 10.6% Sentiment54/100

Weighted news tone is neutral across 36 relevant articles.

Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks Insiders8 / 0

8 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings9d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.24 USD-0.4%2.51 USD6.09 USD0.31-26.291.2MOff
24 Jul 20262.25 USD-5.5%2.51 USD6.15 USD0.71-27.351.1MOn
17 Jul 20262.38 USD-14.4%2.51 USD6.21 USD1.05-26.461.4MOn
10 Jul 20262.78 USD-9.2%2.51 USD6.28 USD1.28-20.071.8MOn
3 Jul 20263.06 USD1.7%2.50 USD6.34 USD1.37-12.881.3MOn
26 Jun 20263.01 USD2.0%2.48 USD6.39 USD1.43-15.761.3MOn
19 Jun 20262.95 USD-1.7%2.46 USD6.45 USD1.32-23.022.0MOn
12 Jun 20263.00 USD-11.8%2.44 USD6.50 USD1.21-21.917.5MOn
5 Jun 20263.40 USD43.5%2.42 USD6.56 USD0.96-11.84101.5MOn
29 May 20262.37 USD0.9%2.39 USD6.62 USD0.65-42.70351.2KOff
22 May 20262.35 USD11.4%2.41 USD6.67 USD0.49-42.84252.4KOff
15 May 20262.11 USD-5.8%2.46 USD6.73 USD0.36-49.17424.3KOff
8 May 20262.24 USD-0.9%2.53 USD6.79 USD0.47-47.43252.2KOff
1 May 20262.26 USD-2.6%2.58 USD6.84 USD0.61-45.30290.3KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.